These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2936977

  • 1. Antimyoclonic properties of S2 serotonin receptor antagonists in the rat.
    Pranzatelli MR, Snodgrass SR.
    Neuropharmacology; 1986 Jan; 25(1):5-12. PubMed ID: 2936977
    [Abstract] [Full Text] [Related]

  • 2. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR, Snodgrass SR.
    Brain Res; 1986 Jan 29; 364(1):67-76. PubMed ID: 3484993
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT1A, 5-HT1B/1D and 5-HT2A receptor antagonists.
    Nielsen CK.
    Eur J Pharmacol; 1998 Nov 20; 361(2-3):185-90. PubMed ID: 9865507
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
    Pranzatelli MR.
    Arch Neurol; 1994 Jun 20; 51(6):605-17. PubMed ID: 7515228
    [Abstract] [Full Text] [Related]

  • 13. Effects of selective 5-hydroxytryptamine-2 and nonselective 5-hydroxytryptamine antagonists on the differential-reinforcement-of-low-rate 72-second schedule.
    Marek GJ, Seiden LS.
    J Pharmacol Exp Ther; 1988 Feb 20; 244(2):650-8. PubMed ID: 2894458
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T, Walker EA, Woods JH.
    J Pharmacol Exp Ther; 1991 Sep 20; 258(3):999-1007. PubMed ID: 1890629
    [Abstract] [Full Text] [Related]

  • 16. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PF, Laduron PM.
    Mol Pharmacol; 1985 Jun 20; 27(6):600-11. PubMed ID: 2860558
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin.
    Paul D, Mana MJ, Pfaus JG, Pinel JP.
    Pharmacol Biochem Behav; 1988 Nov 20; 31(3):641-7. PubMed ID: 3251248
    [Abstract] [Full Text] [Related]

  • 18. pH-dependent modulation of agonist interactions with [3H]-ketanserin-labelled S2 serotonin receptors.
    Battaglia G, Shannon M, Borgundvaag B, Titeler M.
    Life Sci; 1983 Nov 14; 33(20):2011-6. PubMed ID: 6645787
    [Abstract] [Full Text] [Related]

  • 19. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes.
    Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):51-6. PubMed ID: 9650847
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.